(Q38079140)

28 August 2017

1 reference

title

Current management strategies and emerging treatments for functional dyspepsia (English)

1 reference

28 August 2017

1

Michael Camilleri

1 reference

28 August 2017

Vincenzo Stanghellini

series ordinal

2

1 reference

PubMed ID

23381190

28 August 2017

language of work or name

English

0 references

publication date

5 February 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

3

1 reference

28 August 2017

187-194

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.11

28 August 2017

0 references

cites work

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Economic costs of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Gastroduodenal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Guidelines for the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: a 7-year cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Comparison between empirical prokinetics, Helicobacter test-and-treat and empirical endoscopy in primary-care patients presenting with dyspepsia: a one-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Dyspepsia management in primary care: a decision analysis of competing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Influence of buspirone on gastric sensorimotor function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Long-term improvement in functional dyspepsia using hypnotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Review article: current treatment options and management of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Current medical treatments of dyspepsia and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Do distinct dyspepsia subgroups exist in the community? A population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Relationship between symptoms and ingestion of a meal in functional dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

American Gastroenterological Association medical position statement: evaluation of dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Initial management strategies for dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Eradication of Helicobacter pylori for non-ulcer dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Endoscopy in GERD: Boondoggle, Diagnostic Test, or Risk Management Tool?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Psychological interventions for non-ulcer dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Psychotherapy in functional dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.11

Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants

31 March 2020

1 reference

12 December 2020

Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia

1 reference

12 December 2020

Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials

1 reference

12 December 2020

Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria

1 reference

12 December 2020

Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus.

1 reference

12 December 2020

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

1 reference

12 December 2020

Clinical findings confirm national guidelines regarding primary gastroscopy for upper gastrointestinal symptoms.

1 reference

12 December 2020

Pharmacological interventions for non-ulcer dyspepsia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2013.11

1 reference

PubMed ID

23381190

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23381190